Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 63-85
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Dynamics of antibody response to CoronaVac vaccine
Marcela Helena Gambim Fonseca, Tamiris de Fátima Goebel de Souza, Fernanda Montenegro de Carvalho Araújo, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2139-2148
Open Access | Times Cited: 54
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19
Salvatore Chirumbolo, Luigi Valdenassi, Vincenzo Simonetti, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107777-107777
Open Access | Times Cited: 50
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 18
Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
Ting Xue, Xiaomei Kong, Liang Ma
Journal of Fungi (2023) Vol. 9, Iss. 8, pp. 812-812
Open Access | Times Cited: 17
An update on the pathogenic role of IL-6 in rheumatic diseases
Yuko Kaneko, Tsutomu Takeuchi
Cytokine (2021) Vol. 146, pp. 155645-155645
Open Access | Times Cited: 25
COVID-19 Delta variants—Current status and implications as of August 2021
Flora Yu, Lok Ting Lau, Manson Fok, et al.
Precision Clinical Medicine (2021) Vol. 4, Iss. 4, pp. 287-292
Open Access | Times Cited: 24
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5128-5148
Open Access | Times Cited: 16
High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
Rita Jaafar, Céline Boschi, Sarah Aherfi, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2177-2177
Open Access | Times Cited: 22
Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
Martina Barnova, Anna Bobčáková, Veronika Urdova, et al.
Physiological Research (2021), pp. S227-S247
Open Access | Times Cited: 21
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy
Anthony T. Reder, Olaf Stüve, Stephanie Tankou, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 6, pp. 648-656
Open Access | Times Cited: 14
PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, et al.
Heliyon (2021) Vol. 7, Iss. 10, pp. e08124-e08124
Open Access | Times Cited: 17
Cascading failure of complex networks based on load redistribution and epidemic process
Ziyang Jin, Dongli Duan, Ning Wang
Physica A Statistical Mechanics and its Applications (2022) Vol. 606, pp. 128041-128041
Closed Access | Times Cited: 12
Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy
S. Sankaranarayanan, Mugdha Mohkhedkar, Janakiraman Vani
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 9, pp. 166432-166432
Open Access | Times Cited: 10
Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection
Samaneh Sajjadi, Sepideh Hejazi, Sahar Ravanshad, et al.
Gene (2022) Vol. 834, pp. 146550-146550
Open Access | Times Cited: 10
COVID‐19 vaccine associated cervical lymphadenopathy: a case series
Chelsea L. Heaven, Lucy G. Barber, Omid Ahmadi, et al.
ANZ Journal of Surgery (2022) Vol. 92, Iss. 9, pp. 2286-2291
Open Access | Times Cited: 9
Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019
Agata Jędrzejewska, Ada Kawecka, Alicja Braczko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13140-13140
Open Access | Times Cited: 5
Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 35-35
Open Access | Times Cited: 8
Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance
Diwenxin Zhou, Shuai Zhao, Keting He, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment
Udeep Chawla, Manoj Kumar Kashyap, Amjad Husain
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 3911-3922
Open Access | Times Cited: 10
Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal–fetal transference of antibodies in mice
Gabrielle Gimenes Lima, Amanda Izeli Portilho, Elizabeth De Gaspari
Pathogens and Disease (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 7
Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
Kriti Khare, Rajesh Pandey
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities
Modjtaba Emadi‐Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 7
Assessment of a rapid pan-antibody dot test for detection of antibodies against SARS-CoV-2
Md. Ahsanul Haq, Maha Jamiruddin, Mohib Ullah Khondoker, et al.
Bangladesh Journal of Medical Science (2021), pp. 131-139
Open Access | Times Cited: 6
Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19
S. K. CHATTERJEE, Snigdha Saha, Maria Nilda M. Muñoz
Exploration of Immunology (2021)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top